PeekMed, a Portuguese company developing an AI-based 3D pre-operative planning system for orthopedic surgery, has announced the close of a €3 million ($3.7 million) Series
Docbot Raises $4 Million for Clinical Decision Support Platform
Docbot, which develops an automated software platform that provides actionable real-time computer vision and machine learning detection, automated reporting, and data-driven analytic tools to improve
PathAI Raises $165 Million for Clinical Decision Support Platform
PathAI, a provider of AI-powered clinical decision support tools for pathology laboratories, announced the closing of its $165 million Series C financing round. The financing
Elucid Secures $8 Million for Precision Medicine Platform
Elucid, a precision medicine software platform for cardiovascular disease, raised $8 million in Series A financing. The funding round was led by MedTex Ventures and
Clinical Decision Support Companies Raised $661 Million in Q1 2021
Clinical Decision Support software companies raised $661 million in 15 venture capital (VC) funding rounds in Q1 2021, compared to $505 million in 12 funding
MCI Onehealth Acquires Precision Medicine Company Khure Health
MCI Onehealth, a chat assistant application that informs, guides, and helps patients find the exact kind of care they need, has completed its previously announced
Halma Acquires Clinical Decision Support Company PeriGen for $58 Million
Halma, a British group of safety equipment companies that make products for hazard detection and life protection, acquired PeriGen, which uses an artificial intelligence-enabled clinical
VieCure Raises $25 Million for Clinical Decision Support Platform
VieCure, a real-time clinical decision support system, announced the closing of its $25 million Series A growth equity investment round, led by Northpond Ventures. An
Scipher Medicine Raises $82 Million for Precision Immunology Platform
Scipher Medicine, an AI-powered precision immunology platform that matches patients with effective therapy, announced the completion of its $82 million Series C financing led by
NeoGenomics to Acquire Clinical Decision Software Company Trapelo Health
NeoGenomics, a provider of cancer-focused genetic testing services and global oncology contract research services, agreed to acquire Intervention Insights (dba Trapelo Health), a clinical decision